Success Metrics

Clinical Success Rate
93.0%

Based on 66 completed trials

Completion Rate
93%(66/71)
Active Trials
16(15%)
Results Posted
30%(20 trials)
Terminated
5(5%)

Phase Distribution

Ph phase_3
9
8%
Ph phase_1
12
11%
Ph early_phase_1
2
2%
Ph not_applicable
62
57%
Ph phase_2
20
19%

Phase Distribution

14

Early Stage

20

Mid Stage

9

Late Stage

Phase Distribution105 total trials
Early Phase 1First-in-human
2(1.9%)
Phase 1Safety & dosage
12(11.4%)
Phase 2Efficacy & side effects
20(19.0%)
Phase 3Large-scale testing
9(8.6%)
N/ANon-phased studies
62(59.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

66 of 77 finished

Non-Completion Rate

14.3%

11 ended early

Currently Active

16

trials recruiting

Total Trials

108

all time

Status Distribution
Active(24)
Completed(66)
Terminated(11)
Other(7)

Detailed Status

Completed66
Recruiting14
unknown7
Withdrawn6
Not yet recruiting6
Terminated5

Development Timeline

Analytics

Development Status

Total Trials
108
Active
16
Success Rate
93.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (1.9%)
Phase 112 (11.4%)
Phase 220 (19.0%)
Phase 39 (8.6%)
N/A62 (59.0%)

Trials by Status

unknown76%
enrolling_by_invitation22%
completed6661%
withdrawn66%
not_yet_recruiting66%
recruiting1413%
active_not_recruiting22%
terminated55%

Recent Activity

Clinical Trials (108)

Showing 20 of 108 trialsScroll for more
NCT06671483Phase 3

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Recruiting
NCT04203173Not Applicable

Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1

Completed
NCT02896842Phase 2

A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML

Completed
NCT07075588Not Applicable

Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure

Recruiting
NCT06457139Not Applicable

Preventing T2DM After GDM With Immediate Postpartum Screening

Recruiting
NCT07168226Phase 2

Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

Recruiting
NCT04572165

Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data

Completed
NCT04334525Not Applicable

Promoting Healthier Eating Among Children in Restaurants

Completed
NCT05247255Early Phase 1

Quadratus Lumborum Block for Total Hip Arthroplasty

Enrolling By Invitation
NCT07615972Not Applicable

Efficacy of a Roller Device Facilitating Self-massage in the Treatment of Chronic Lateral Epicondylitis

Not Yet Recruiting
NCT07593755Not Applicable

Evaluation of Toothpaste Effect in Volunteers With Dental Sensitivity

Completed
NCT06868290Phase 2

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

Recruiting
NCT06639477Not Applicable

Assessing Improvements in Mood and Sleep Trial

Recruiting
NCT06832670Not Applicable

Nursing Strategies to Increase Vaccination Rates in Adolescents: Education, Video Animation and Games

Completed
NCT05040711Not Applicable

mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

Recruiting
NCT04781387Phase 2

Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Completed
NCT07419685Not Applicable

Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste

Completed
NCT07419763Not Applicable

Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste

Completed
NCT07317284Not Applicable

Evaluation and Treatment for Diabetic Peripheral Neuropathy

Completed
NCT07300358Not Applicable

Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
108